Cardiometabolic & Cognitive Effects of Peanut Butter in Prediabetes
ConditionPrediabetes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorPenn State University
About this trial
The purpose of this study is to look at the effect of consuming peanut butter at breakfast on blood sugar control, cognitive function, and heart disease risk factors in middle-aged adults with prediabetes.
Eligibility criteria
Qualifiers
Age 40-65 years
BMI 25 to 40 kg/m2
HbA1c 5.7-6.4%
Low habitual intake of peanut butter (<0.5 Tablespoons/day on average)
Disqualifiers
Hemoglobin <13.2 g/dL for men or < 11.7 g/dL for women at screening
Fasting triglycerides >350 mg/dL at screening
LDL-cholesterol ≥190 mg/dL assessed by the Martin-Hopkins equation at screening
≥10% change in body weight within the 6 months prior to enrollment
Trial design
Treatments tested in this trial
- Peanut butter
- Usual diet
Treatment groups
56 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov